ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 610

Disease Specific Quality Of Life Domains Are Impaired In Patients With Lupus Nephritis?

Meenakshi Jolly1, Zineb Aouhab2, Sergio Toloza3, Ana M. Bertoli4, Ivana Blazevik5, Luis M. Vila6, Ioana Moldovan7, Karina Marianne D. Torralba8, Arif Kaya9, Berna Goker10, Mehmet E. Tezcan11, Seminur Haznedaroglu12, Josiane Bourré-Tessier13, Ann E. Clarke14, D.J. Wallace15, Michael H. Weisman16 and Graciela S. Alarcon17, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Medicine, John H Stroger Hospital, Chicago, IL, 3Hospital San Juan Bautista, Catamarca, Argentina, 4Instituto Reumatológico Strusberg, Cordoba, Cordoba, Argentina, 5University of Buenos Aires, Buenos Aries, Argentina, 6Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 7Loma Linda Univ Medical Center, Loma Linda, CA, 8Rheumatology/Int Med, USC Keck Schl of Medicine, Los Angeles, CA, 9Internal Medicine-Rheumatology, Gazi University Medical School, Ankara, Turkey, 10Internal Medicine-Rheumatology, Gazi University, Ankara, Turkey, 11Rheumatology, Dr. Lutfi Kirdar Kartal EA Hastanesi, Istanbul, Turkey, 12Internal Medicine-Rheumatology, Gazi University School of Medicine, Ankara, Turkey, 13Rheumatology, McGill University, Montréal, QC, Canada, 14Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, 15Cedars-Sinai Medical Center, Los Angeles, CA, 16Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 17Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR/ARHP Annual Meeting 2013

Keywords: lupus nephritis and quality of life, SLE

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects I - Renal, Malignancy, Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Often systemic Lupus Erythematosus (SLE) patients with Lupus Nephritis (LN) require frequent visits with their health care providers, follow up, and exposure to immunosuppressive medications with potential for significant side effects (e.g. fertility). Thus far, studies have not examined the adverse effects of LN using a disease specific patient reported outcome tool, which can address these concerns. Herein, we compare quality of life (QOL) in patients with and without history of LN using a disease specific quality of life (QOL) questionnaire-LupusPRO.

Methods:  

791 SLE patients from North and South America, the Philippines and Turkey completed LupusPRO, which has 12 domains involving health-related quality of life (HRQOL) and non-health related quality of life (N-HRQOL) construct in 33 questions (Domain scores range 0-100; Hi=Better QOL).  Health outcomes including Physician Global Assessment (PGA), Systemic Lupus Erythematous Disease Activity Index (SELENA-SLEDAI) and the SLICC Damage Index were physician-assessed cross-sectionally. Rheumatologists indicated on the ACR criteria if patients had a history of LN (irrespective of current activity). These patient and physician outcomes were compared using Chi square and non parametric statistical tests; p value of ≤ 0.05 was considered significant.

Results:

304/ 791 SLE patients had LN.  Renal biopsy results were available on 184/304 LN patients: 7 LN-WHO Class I; 25-LN Class II; 120 LN Class III or IV or combinations; 29 LN-Class V; 3 LN-Class VI. Demographic, physician assessed and patient reported outcomes are shown in Table 1.

LN patients were younger, had greater disease activity and damage, were more often and on greater dose of prednisone, more often on mycophenolate-mofetil, and reported poorer health outcomes than SLE patients without LN, in both the HRQOL (Lupus medications, procreation, and emotional health) and the NHRQOL (Desires-Goals) constructs.

Conclusion:

LN patients have worse physician and patient reported health outcomes than those without LN. They voiced concerns on several areas (concerns about lupus medications side effects, procreation, emotional health and effects on their personal goals and aspirations), which can be easily assessed with LupusPro.

Table 1: Comparison of health outcomes by Lupus Nephritis Status


Disclosure:

M. Jolly,

GSK,

5,

GSK,

5,

Medimmune,

5,

Medimmune,

5;

Z. Aouhab,
None;

S. Toloza,
None;

A. M. Bertoli,
None;

I. Blazevik,
None;

L. M. Vila,
None;

I. Moldovan,
None;

K. M. D. Torralba,
None;

A. Kaya,
None;

B. Goker,
None;

M. E. Tezcan,
None;

S. Haznedaroglu,
None;

J. Bourré-Tessier,
None;

A. E. Clarke,
None;

D. J. Wallace,
None;

M. H. Weisman,
None;

G. S. Alarcon,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2013

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disease-specific-quality-of-life-domains-are-impaired-in-patients-with-lupus-nephritis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology